Log in to save to my catalogue

MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy

MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7291039

MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy

About this item

Full title

MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy

Publisher

Switzerland: MDPI AG

Journal title

Journal of clinical medicine, 2020-05, Vol.9 (5), p.1427

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Gastric cancers have been historically classified based on histomorphologic features. The Cancer Genome Atlas network reported the comprehensive identification of genetic alterations associated with gastric cancer, identifying four distinct subtypes- Epstein-Barr virus (EBV)-positive, microsatellite-unstable/instability (MSI), genomically stable an...

Alternative Titles

Full title

MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7291039

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7291039

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm9051427

How to access this item